The Prevalence of Fanconi Anemia Among Patients with De Novo Acute Myelogenous Leukemia.

被引：0
|
作者：
Rochowski, Andrzej [1 ]
Rosenberg, Philip S. [2 ]
Alonzo, Todd A. [3 ]
Gerbing, Robert B. [4 ]
Lange, Beverly [5 ]
Alter, Blanche P.
机构：
[1] Childrens Natl Med Ctr, Ctr Canc & Blood Disorders, Washington, DC 20010 USA
[2] NCI, Biostat Branch, Rockville, MD USA
[3] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
[4] Childrens Oncol Grp, Arcadia, CA USA
[5] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：918 / 918
页数：1
相关论文
共 50 条
  • [1] Estimation of the prevalence of Fanconi anemia among patients with de novo acute myelogenous leukemia who have poor recovery from chemotherapy
    Rochowski, Andrzej
    Rosenberg, Philip S.
    Alonzo, Todd A.
    Gerbing, Robert B.
    Lange, Beverly J.
    Alter, Blanche P.
    LEUKEMIA RESEARCH, 2012, 36 (01) : 29 - 31
  • [2] p73 mutations and expression in adult de novo acute myelogenous leukemia.
    Stirewalt, DL
    Cluman, B
    Appelbaum, FR
    Willman, CL
    Radich, JP
    BLOOD, 1998, 92 (10) : 221A - 221A
  • [3] A screen for acquired Fanconi anemia pathway defects in acute myeloid leukemia.
    Shimamura, A
    Macari, TJ
    Svenson, JL
    D'Andrea, AD
    BLOOD, 2002, 100 (11) : 324A - 324A
  • [4] Homoharringtonine based triple-drug regimen as induction chemotherapy for de novo acute myelogenous leukemia.
    Jin, Jie
    Qian, Wenbin
    Liu, Hui
    Jian, Daozi
    Mai, Wenyuan
    Tong, Hongyan
    Men, Haitao
    BLOOD, 2006, 108 (11) : 566A - 566A
  • [5] de novo acute myelogenous leukemia (AML)-associated cytogenetic abnormalities in patients with acquired severe aplastic anemia.
    Kim, SH
    Lee, KA
    Yoon, HR
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A167 - A167
  • [6] Autoimmune hemolytic anemia in patients with de novo acute myelocytic leukemia
    Tamura, H
    Ogata, K
    Yokose, N
    An, E
    Kamikubo, K
    Dan, K
    Kajii, E
    Nomura, T
    ANNALS OF HEMATOLOGY, 1996, 72 (01) : 45 - 47
  • [7] Down syndrome patients with relapsed acute myelogenous leukemia.
    Loew, TW
    Gamis, A
    Smith, FO
    Massey, GV
    Woods, WG
    Hilden, JM
    Lange, B
    Alonzo, TA
    Chang, M
    Gerbing, RB
    BLOOD, 2004, 104 (11) : 215B - 215B
  • [8] Loss of heterozygosity in childhood de novo acute myelogenous leukemia
    Sweetser, DA
    Chen, CS
    Blomberg, AA
    Flowers, DA
    Galipeau, PC
    Barrett, MT
    Heerema, NA
    Buckley, J
    Woods, WG
    Bernstein, ID
    Reid, BJ
    BLOOD, 2001, 98 (04) : 1188 - 1194
  • [9] A high BMI is a risk factor in younger patients with de novo acute myelogenous leukemia
    Crysandt, Martina
    Kramer, Michael
    Ehninger, Gerhard
    Bornhaeuser, Martin
    Berdel, Wolfgang E.
    Serve, Hubert
    Roellig, Christoph
    Kaifie, Andrea
    Jost, Edgar
    Brummendorf, Tim H.
    Wilop, Stefan
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (01) : 17 - 24
  • [10] Prognostic significance of dysplastic features of hematopoiesis in patients with de novo acute myelogenous leukemia
    Kahl, C
    Florschutz, A
    Muller, G
    JentschUllrich, K
    Arland, M
    Leuner, S
    Franke, A
    Hoffkes, HG
    ANNALS OF HEMATOLOGY, 1997, 75 (03) : 91 - 94
12345